Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective observational study of ageing and clinical outcomes in people living with HIV in England and Ireland
2012-003581-40Phase 4Unknown
- Sponsor
- Imperial College London
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV) and Seroconversion Syndrome, sponsored by Imperial College London. Primary endpoint: Clinical events at baseline (prevalence). Status: unknown.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)Seroconversion Syndrome
Beyond the preview
Go deeper on 2012-003581-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003581-40.